Eli Lilly Corp. buy JPMorgan Chase & Co.
Start price
11.07.24
/
50%
€852.80
Target price
11.07.25
€919.70
Performance (%)
-20.85%
End price
12.07.25
€675.00
Summary
This prediction ended on 12.07.25 with a price of €675.00. The price of Eli Lilly Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.85%. JPMorgan_Chase___Co_ has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. Dividends of €3.85 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | -9.747% | -9.747% | 45.720% |
| iShares Core DAX® | 3.258% | 2.069% | 10.102% |
| iShares Nasdaq 100 | 5.697% | -0.604% | 28.972% |
| iShares Nikkei 225® | 7.770% | -4.746% | 52.094% |
| iShares S&P 500 | 2.795% | 2.251% | 23.747% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at JPMorgan Chase & Co. from $900.00 to $1,000.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for Eli Lilly Corp.
Stopped prediction by JPMorgan_Chase___Co_ for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€843.20
13.09.24
13.09.24
€992.31
13.09.25
13.09.25
-23.74%
14.09.25
14.09.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€726.70
01.05.24
01.05.24
€842.40
01.05.25
01.05.25
-2.30%
02.05.25
02.05.25